Clinical trial · Interventional
Heart Rate Variability (HRV) in Pituitary Adenoma
A Study to Observe the Change of the Biological Signal (Heart Rate) During the Combined Pituitary Stimulation Test
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Several studies have been reported that heart rate is known to be associated with prognosis in chronic diseases and acute diseases. For example, a decrease in heart rate following myocardial infarction may lead to a higher mortality rate. It is also known to predict heart failure, diabetic neuropathy, and even depression. The combined pituitary function test artificially induces hypoglycemia to observe the secretion of pituitary hormone. The degree of change in heart rate during hypoglycemia can predict the adequacy of the test, and heart rate can be changed according to the characteristic of the tumor. Also, the prognosis can be predicted based on this. In our study, we used a licensed device approved by KFDA (Korea Food and Drug Administration) to measure heart rate variability in patients with pituitary adenoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pituitary Adenoma | Pituitary Neuroendocrine Tumor | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| T-REX TRI00A | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Case Evaluation by T-REX TRI00A
- description
- Case evaluation consists of confirmation of hospital visit dates, any side effects of device, T-REX TRI00A
- interventionNames
- Device: T-REX TRI00A
Primary outcomes (1)
- measure
- Changes in Heart rate variability according to the types of pituitary adenoma
- timeFrame
- 5 month of initial recruit
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * Over 19 year old * Those with Normal blood pressure range: 90mmHg \<systolic \<140mmHg, 60mmHg \<diastolic \<100mmHg * Voluntary participants who visited Seoul St. Mary's Hospital Exclusion Criteria: * Those who have been diagnosed with sleep disorders, diabetes, arrhythmia, psychiatric disorder, physical or mental breakdown, drug addicts * Diabetes, hypertension, cardiovascular disease diagnosed by taking a drug related to the disease * Pregnant or lactating women * Those who drank within 12 hours before participating in the trial * Those who are deemed inappropriate by clinical trial researchers
References
Publications (0)
Data not yet available